Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Energized About Organic Growth Opportunities In Trauma, Spine Units

This article was originally published in The Gray Sheet

Executive Summary

Zimmer, the leading player in the hip and knee implant markets, reports promising signs of life from several of its non-reconstructive businesses

You may also be interested in...



Medtronic Ends Ongoing Spinal Litigation With $1.35 Bil. IP Buy

Artificial disc manufacturers may be at risk of being sued by Medtronic concerning disc-space clearing techniques and toolsets following the firm's $1.35 bil. acquisition of spine-related intellectual property

Ortho Firms Feel DoJ Probe Price As Stocks Fall In Q1; Will Zimmer Diversify?

The federal government's mounting scrutiny of orthopedic industry pricing practices for hip and knee replacement implants could convince Zimmer to more aggressively seek a presence in the artificial disc arena

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022042

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel